Integrated genomic analysis and CRISPRi implicates EGFR in Alzheimer's disease risk
Yuk Yee Leung, Pavel P. Kuksa, Luke Carter, Jeffrey Cifello, Emily Greenfest‐Allen, Otto Valladares, Louisa Boateng, Shannon Laub, Natalia M. Tulina, Sofia Moura, Aura María Ramírez, Katrina Celis, Fulai Jin, Ru Feng, Gao T. Wang, , Li‐San Wang
The paper identifies EGFR as a potential therapeutic target in Alzheimer's disease by linking a risk variant to increased EGFR expression in brain cell types through genomic analysis and CRISPRi validation.
npj Dementia · Dec 16, 2025Peer-reviewedGenetic & Genomic Medicine